US Stock MarketDetailed Quotes

EVOK Evoke Pharma

Watchlist
  • 2.7800
  • -0.1000-3.47%
Trading Mar 27 09:55 ET
4.15MMarket Cap-0.99P/E (TTM)

About Evoke Pharma Company

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

Company Profile

SymbolEVOK
Company NameEvoke Pharma
Listing DateSep 25, 2013
Issue Price12.00
Founded2007
CEOMr. Matthew J. D'Onofrio
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address420 Stevens Avenue,Suite 230
CitySolana Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92075-2074
Phone1-858-345-1494
Websitehttp://www.evokepharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Matthew J. D'Onofrio
  • Chief Executive Officer, Director, Principal Accounting Officer, President, Chief Operating Officer, Secretary and Treasurer
  • 857.37K
  • Dr. Marilyn R. Carlson, D.M.D.,M.D.
  • Chief Medical Officer
  • 728.49K
  • Mark A. Kowieski
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Cam L. Garner
  • Chairman of the Board
  • 102.95K
  • Greg Pyszczymuka
  • Independent Director
  • --
  • Vickie W. Reed
  • Independent Director
  • 85.31K
  • Malcolm R. Hill, Pharm.D.
  • Independent Director
  • 79.18K
  • Benjamin Smeal
  • Independent Director
  • --
  • Dr. Todd C. Brady, M.D.,PhD
  • Independent Director
  • 79.43K
  • Dr. Kenneth J. Widder, M.D.
  • Independent Director
  • 77.54K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
284.000
KB Home
KBH
59.895
Taylor Morrison Home
TMHC
61.645
4
D.R. Horton
DHI
130.910
5
Lennar Corp
LEN
119.225
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings